Latest posts tagged with #SWPRN25 on Bluesky
I did my best to channel the skills of @thementalelf.bsky.social at the @swpharmres.bsky.social Innovation Day for those who couldn't make it in person. I don't think I was up to their excellent standards, but if you search #SWPRN25 you should be able to get a taster of the day.
#PharmacyResearch
Finally, there's still a chance for attendees to share feedback. These events are very much shaped by the requests we get from network members, so please do let us know your thoughts about the content, location, catering or anything else! #SWPRN25 tinyurl.com/mpadknnf
See you next time!
🧵 (6/6)
We will be sharing more from the day including profiles of poster presenters and their work over the next few weeks. You can use the hashtag #SWPRN25 to look back at a running commentary of the talks from the day.
🧵 (3/6)
A collage picture including a group of conference attendees, a screenshot that reads: "Opportunities aren't found; they're created with curiosity, courage and connection" an image of a badge that says "Ask me about our research network: SWPRN South West Pharmacy Research Network", an image of the conference chair on stage and a diagram showing the interplay between Clinical Research, Community Pharmacy, Enhancing Learning and Income and Shaping Clinical Practice.
What a fantastic day at the #SWPRN25 network Innovation Day yesterday. A brilliant range of #PharmacyResearch talks, workshops, posters and networking opportunities.
Huge thanks to the organising committee, our speakers, poster presenters, workshop leaders and attendees.
🧵(1/6)
Well, that's a wrap on the #SWPRN25 Innovation Day - thank you to all the organisers and especially to Matthew Jones who masterminded the whole thing.
At the end of the day we were all challenged to make one commitment to keep the momentum going - anybody want to share theirs? #PharmacyResearch
#SWPRN25 Poster prizes runners up and winners! (2/2)
Most visually attractive poster (runner-up): Sarah Mulholland
Most visually attractive poster (winner): Amy Long
Delegates choice (runner up): Karon Arnold
Delegates choice (winner): Amy Long
Thank you to everyone who brought a poster!
#SWPRN25 Poster prizes runners up and winners! (1/2)
NHS (runner-up): Theresa Chan
NHS (winner): Jaina Nyame
University (runner-up): Sarah Jones
University (winner): Charley Hobson-Merrett
Key messages from the other workshop on improving Quality Improvement:
"If you can't measure it, you can't control it"
"All improvements require change, but not all change is improvement"
"Bring people with you - break out of your pharmacy silo!"
Thanks to Ya-Hui Liang for feeding back. #SWPRN25
A golden envelope and a piece of paper saying congratulations you've been awarded £20,000
Another discussion starter! Golden envelopes and theoretical funding awards - we've been asked to think about how we could spend £20k to support pharmacy research capacity. How would we demonstrate impact? #SWPRN25
A room with groups of people round tables, talking and writing on flip chart paper
Lots of animated discussions in the room #SWPRN25
Some of the group feedback includes the threats posed by pharmacy workforce shortages (including making backfill difficult) and financial challenges (especially in community pharmacy). Opportunities include community pharmacy giving access to different patient populations for research. #SWPRN25
Slide: research delivery in pharmacy SWOT discussion
Straight away we are being asked to put our thinking caps on and consider pharmacy as part of research delivery: what are the strengths, weaknesses, opportunities and threats.
#SWPRN25
Your correspondent is in the @nihr.bsky.social Research Delivery Network workshop, so expect some updates from there #SWPRN25
After a very busy lunch break filled with poster presentations, networking and food, our afternoon kicks off with two workshop options:
(1) Improving the quality of Quality Improvement and
(2) Working with the NIHR Research Delivery Networks
#SWPRN25
Impact: RUH Study: Inform future direction of BCMA scanning and implementation Department: Trust Medication Safety Improvement Group priority Profile building Connections for future collaboration Proof of concept – release to research Changing culture Individuals: Confidence in research Build research pillar of practice “Slow Thinking” Publications
Mandy concludes by reflecting on the benefits of being involved for the trust, the pharmacy department and the individuals. This includes building research skills for Advanced and Consultant practice and a way to improve job satisfaction (and perhaps staff retention?) #SWPRN25
Participants perceived that they have limited knowledge on the evidence surrounding BCMA supporting patient safety There was consensus among participants regarding the impact of strong leadership on increasing the use of BCMA by nurses Participants perceived that there is a need for education not training on the use of BCMA. When we asked participants if there any other staff groups who can support the use of BCMA, they mentioned pharmacy and IT staff
The realist approach revealed work-arounds. Some nurses reported that without understanding the 'why' of implementing the scanning system, there is a temptation to work around it if it speeds up medicines administration. It also help understand other practical barriers #SWPRN25
Phase 1: Involved a narrative review to develop an initial programme theory. Phase 2: Utilised interviews with key informants to refine the initial programme theory. Phase 3: We are using observation of medication administration, analysis of BCMA alert data, and interviews with nurses and patients to test the programme theory. Phase 4: We will triangulate the data to refine and finalise the programme theory together with recommendations for practice.
Aseel now outlines the study design including the importance of having a project advisory group with a wide range of representation including patients, practitioners and digital implementation experts. #SWPRN25
Mandy talks about the start of RUH Bath involvement thanks to a conversation at the 2024 Innovation Day!
She also reflects on some of the challenges to getting involved as a third site including funding applications with very tight deadlines and being realistic about people's capacity.
#SWPRN25
The impact of BarCode Medication Administration on Patient Safety (‘BCMAPS’) in UK hospital settings: a mixed-methods realist evaluation Dr Aseel Mahmoud Health Services Researcher, Centre of Medication Safety and Service Quality, Imperial College Healthcare NHS Trust Mandy Slatter Pharmacy Practice Research Lead Royal United Hospitals Bath NHS Foundation Trust
Aseel describes the background: Barcode medication administration may improve patient safety by using barcode scanning to ensure the right drug and dose are given to the right patient. Implementation of these systems is complex so lends itself to a realist evaluation approach. #SWPRN25
Black and white photo of a woman on stage presenting a talk on evaluating bar code medication administration
Our final pair of talks this morning is by Aseel Mahmoud and Mandy Slatter who are telling us about a mixed-methods realist evaluation of bar code medication administration on patient safety #SWPRN25
Apologies for consistently missing a 'P' off IMPPP! The perils of live posting 🙃
IMPPP: Improving Medicines use in People with Polypharmacy in Primary Care
#SWPRN25
Schematic of the IMPP study: A pragmatic, open-label, two-arm, parallel cluster-randomised trial was conducted in UK general practices providing National Health Service primary medical care. Practices were required to use the EMIS electronic health records system and have more than 4000 registered patients. For inclusion in the study, participants were required to be aged 18 years or older, prescribed at least five regular medications (ie, medicines recorded in the clinical system as repeat prescriptions, and thus available for recurrent ordering by patients without having to see a clinician) irrespective of when the drug was last issued, and with at least one indicator of potentially inappropriate prescribing identified by an informatics tool. Practices were randomly allocated to deliver the polypharmacy intervention or continue usual care. The complex intervention comprised a structured, collaborative, and patient-centred approach to medication review, supported by informatics, clinician training, performance feedback, and financial incentivisation. In each practice, adults receiving five or more regular medications, with at least one indicator of potentially inappropriate prescribing, were reviewed over a 6-month period. The primary outcome was number of indicators of potentially inappropriate prescribing at 26 weeks’ follow-up, analysed on an intention-to-treat basis.
Simon reflects on the fact that IMPP was a study that felt very embedded in real world practice - a way of understanding a service already delivered by clinical pharmacists in GP surgeries but in a more structured way. #SWPRN25
Personal: Professional development. Area of interest (polypharmacy, deprescribing). Area of work/expertise. Relevant to my role as primary care pharmacist. Training. Dedicated time for GP-Pharmacist discussion. Research! Patients: Clinical: Medicines Optimisation, Safety, Cost: Patient Centred Care Practice: Funding (NIHR portfolio), Education, Staff development Results: Outcome measures? Quality: Targeted - using IT case-finding tool.
Simon now reflects on his role in the study. The importance of being open to learning both in relation to carrying out the research, but also in relation to the actual process of carrying out the polypharmacy reviews themselves. #SWPRN25
Improvement in 1-in-4 patients with less multimorbidity or ≤8 meds Strong evidence that interventions focused on limited problems work Need holistic measure reflecting patient perspectives Quality of life Broad reaching May be insensitive to changes achieved through med review
Rupert reflects on possible reasons that IMPP did "not work" with important points about medicines related research in general. Issues such as #polypharmacy are necessarily complicated to research. It can also be hard to work out what the right outcome measures are. #SWPRN25
Key Findings: Potentially inappropriate prescribing did not improve No evidence for cost-effectiveness Some evidence from improved treatment burden Weak evidence for small safety benefit in less complex patients Evidence of good patient satisfaction and patient-centred care Positive perception of interprofessional collaborative discussion
Rupert discusses some of the benefits of interprofessional collaboration: Strengthening teamwork & collaboration; Learning together and building confidence and Working together to tackle complex care as well as overall key findings #SWPRN25
We are the first audience to hear about IMPP since the publication of one of their key papers last week! #SWPRN25 #polypharmacy #pharmacyresearch
The team includes researchers from @apexcomms.bsky.social and @capcbristol.bsky.social as well as Keele, Munich, Edinburgh and Alberta
Lots of really exciting conversations about the possibilities of pharmacy research...
A challenge to us in the @uwebristolofficial.bsky.social Centre for Health and Clinical Research to get going with more!
#SWPRN25
Black and white photo of a man on stage talking about the IMPP study
The next talk is by Rupert Payne and Simon Strange, telling us about the IMPP study: Improving Medicines use in People with Polypharmacy in Primary Care #SWPRN25
“From Clinical Services to Clinical Research - and Back Again” My Journey: Unlocking the Potential of Research in Community Pharmacy to Enhance Clinical Care …. and Financial Sustainability Jonathan Campbell, Community Pharmacy Research Fellow, South West Central Regional Research Delivery Network (SWC RRDN)
Jonathan Campbell reflects on his experiences with the RAPID IMMUNE TEST and talks passionately about the benefits of community pharmacy becoming involved in research, including addressing the practical barriers and managing imposter syndrome. #SWPRN25
Support from the Regional Research Delivery Network (RRDN) and Integrated Care Board (ICB) was crucial. Community pharmacies are not necessarily equipped like GP surgeries. Understand the scope and boundaries for clinical decision-making in pharmacies. Community pharmacy and GP patient populations were different
Andrew Turner outlines some of the lessons learned by the @capcbristol.bsky.social research team about involving community pharmacy in the RAPID IMMUNE TEST study.
It was important to understand the differences between community pharmacy settings and traditional GP practice research sites #SWPRN25
